Pharma Tech Solutions, Inc. et al v. Lifescan, Inc. et al

Filing 58

ORDER Granting 57 Stipulation of Dismissal. Pharma Tech's claims against LifeScan of literal infringement of all claims of the 069 patent and all claims of the 411 patent are Dismissed with prejudice. Signed by Judge Richard F. Boulware, II on 6/6/2017. (Copies have been distributed pursuant to the NEF - SLD)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

Gregory L. Diskant (admitted pro hac vice)
Eugene M. Gelernter (admitted pro hac vice)
PATTERSON BELKNAP WEBB & TYLER LLP
1133 Avenue of the Americas
New York, NY 10036
Phone: [phone]
Fax:
[phone]
Email: [e-mail]
[e-mail]
Charles D. Hoffmann (admitted pro hac vice)
Sean R. Marshall (admitted pro hac vice)
HOFFMANN MARSHALL & STRONG LLP
116 W 23rd Street, Suite 500
New York, NY 10011
Phone: [phone]
Fax:
[phone]
Email: [e-mail]
[e-mail]
Kelly A. Evans (NV Bar #7691)
Chad R. Fears (NV Bar #6970)
EVANS FEARS & SCHUTTERT L.L.P.
2300 West Sahara Avenue
Suite 1130
Las Vegas, NV 89102
Phone: [phone]
Fax:
[phone]
Email: [e-mail]
[e-mail]
Attorneys for Defendants LifeScan, Inc.;
LifeScan Scotland, Ltd.; and Johnson & Johnson

18
19

UNITED STATES DISTRICT COURT

20

DISTRICT OF NEVADA

21
22
23
24

PHARMA TECH SOLUTIONS, INC. and
DECISION IT CORP.,
Plaintiffs,
vs.

25

LIFESCAN, INC., LIFESCAN SCOTLAND,
LTD. and JOHNSON AND JOHNSON,

26

Defendants.

27
28

Case No. 2:16-cv-00564-RFB-PAL
STIPULATION AND ORDER

1

WHEREAS Plaintiffs Pharma Tech Solutions, Inc. and Decision IT Corp. (collectively

2

“Pharma Tech”) have alleged in this action, inter alia, that Defendants LifeScan Inc., LifeScan

3

Scotland, Ltd. and Johnson & Johnson (collectively, “LifeScan”) literally infringe U.S. Patent Nos.

4

6,153,069 (“the ’069 patent”) and 6,413,411 (“the ’411 patent”) (collectively, the “Asserted

5

Patents”) by making, using, importing, exporting, offering to sell, and selling OneTouch Ultra blood

6

glucose test strips and meters (the “Accused Products”); and

7

WHEREAS LifeScan has disputed this allegation; and

8

WHEREAS LifeScan has provided Pharma Tech with access to documentation showing the

9

operation of the Accused Products; and

10

WHEREAS Pharma Tech has reviewed this documentation and has concluded that LifeScan

11

does not literally infringe the Asserted Patents by making, using, importing, exporting, offering to

12

sell, or selling the Accused Products; and

13

WHEREAS Pharma Tech now wishes to dismiss its allegations of literal infringement;

14

NOW THEREFORE, IT IS HEREBY STIPULATED, AGREED, AND ORDERED that

15

Pharma Tech’s claims against LifeScan of literal infringement of all claims of the ’069 patent and all

16

claims of the ’411 patent ARE DISMISSED WITH PREJUDICE.

17

///

18

///

19

///

20
21
22
23
24
25
26
27
28
–1–

1

For clarity and the avoidance of doubt, this Stipulation and Order does not in any way affect

2

Pharma Tech’s claim that LifeScan infringes the ’411 patent and the ’069 patent under the doctrine

3

of equivalents.

4

Dated: June 6, 2017

5
6
7
8
9
10
11
12
13
14
15
16
17

EVANS FEARS & SCHUTTERT L.L.P.
/s/ Chad R. Fears
Chad R. Fears, NV Bar No. 6970
Kelly A. Evans, NV Bar No. 7691
2300 West Sahara Avenue
Suite 1130
Las Vegas, NV 89102

FOX ROTHSCHILD LLP
/s/ William Rudy
William Rudy (pro hac vice)
1225 17th St., Ste. 2200
Denver, CO 80202

Gregory Diskant (pro hac vice)
Eugene M. Gelernter (pro hac vice)
PATTERSON BELKNAP WEBB & TYLER LLP
1133 Avenue of the Americas
New York, NY 10036
Charles D. Hoffmann (pro hac vice)
Sean R. Marshall (pro hac vice)
HOFFMANN MARSHALL & STRONG LLP
116 W 23rd Street, Suite 500
New York, NY 10011
Attorneys for Defendants LifeScan, Inc.;
LifeScan Scotland, Ltd.; and Johnson &
Johnson

Attorneys for Plaintiffs Pharma Tech
Solutions, Inc. and Decision IT Corp.

IT IS SO ORDERED:

22

____________________________
Honorable Richard F. Boulware, II
United States District Judge

23

6
Dated: June ______, 2017

18
19
20
21

24
25
26
27
28
–2–